C-reactive protein in patients with bacteremia

Differentiating true bacteremia from blood culture contamination remains a challenge in clinical microbiology. Blood cultures often yield false positives due to contamination, leading to unnecessary treatments. C-reactive protein (CRP) is an acute-phase protein that increases in response to inflammation. Previous studies suggest CRP may help identify infectious processes. However, the utility of CRP in distinguishing true bacteremia from contamination is unclear. No prior work had resolved whether CRP levels reliably indicate infection in this context. This gap motivated the current investigation. Researchers aimed to assess whether early CRP measurements could help differentiate bacteremia from contamination. The study focused on CRP as a potential diagnostic tool. CRP levels were measured in patients with confirmed bacteremia and those with contaminated cultures.

The study aimed to evaluate whether serum CRP levels could distinguish patients with true bacteremia from those with contaminated blood cultures. Researchers wanted to determine if CRP could serve as a reliable indicator of infection. They hypothesized that CRP levels might be higher in patients with bacteremia compared to those with contamination. The motivation stemmed from the need for better diagnostic tools in clinical microbiology. Blood culture contamination is a common issue, and misinterpretation can lead to inappropriate treatment. CRP is a known acute-phase reactant, but its specificity for infection is not well established. The study sought to quantify CRP levels in both groups. The goal was to assess the sensitivity and specificity of CRP in this clinical setting.

The study compared CRP levels in patients with bacteremia and those with contaminated blood cultures. Serum samples were collected on the same day as blood cultures were obtained. CRP concentrations were measured using rate nephelometry. The study included 36 episodes of bacteremia and 21 with contamination. Researchers categorized CRP levels as normal, minimally elevated, or markedly elevated. They compared the distribution of CRP levels between the two groups. The primary outcome was the ability of CRP to differentiate between the groups. Statistical analysis was used to assess the significance of differences.

Among the 36 bacteremia cases, 3 had normal CRP levels and 2 had minimally elevated levels. Of the 21 contamination cases, 2 had normal CRP levels. CRP levels greater than 10 mg/dl were observed in 18 patients, 86% of whom had infection. However, not all of these patients had bacteremia. Moderate CRP elevations (1 to 10 mg/dl) were common in both groups. The study found that CRP levels greater than 10 mg/dl may indicate infection. Yet, these levels were not fully sensitive or specific for bacteremia. The results suggest that CRP alone cannot definitively confirm or rule out bacteremia.

The study found that normal CRP levels do not rule out bacteremia. CRP levels greater than 10 mg/dl may be relatively specific for infection if other causes are excluded. However, CRP is neither completely sensitive nor specific for detecting bacteremia. The authors suggest that CRP should not be used as the sole diagnostic tool. The findings highlight the limitations of CRP in this context. Researchers propose that CRP may still have a role in assessing infection risk. The study emphasizes the need for additional diagnostic methods. The results align with the authors' hypothesis that CRP has limited utility in this setting.